These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

724 related items for PubMed ID: 10961047

  • 1. [Huntington disease. A review].
    Bonilla E.
    Invest Clin; 2000 Jun; 41(2):117-41. PubMed ID: 10961047
    [Abstract] [Full Text] [Related]

  • 2. Selective neuronal degeneration in Huntington's disease.
    Cowan CM, Raymond LA.
    Curr Top Dev Biol; 2006 Jun; 75():25-71. PubMed ID: 16984809
    [Abstract] [Full Text] [Related]

  • 3. Molecular aspects of Huntington's disease.
    Walling HW, Baldassare JJ, Westfall TC.
    J Neurosci Res; 1998 Nov 01; 54(3):301-8. PubMed ID: 9819135
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cellular and subcellular localization of Huntingtin [corrected] aggregates in the brain of a rat transgenic for Huntington disease.
    Petrasch-Parwez E, Nguyen HP, Löbbecke-Schumacher M, Habbes HW, Wieczorek S, Riess O, Andres KH, Dermietzel R, Von Hörsten S.
    J Comp Neurol; 2007 Apr 10; 501(5):716-30. PubMed ID: 17299753
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Selective degeneration in YAC mouse models of Huntington disease.
    Van Raamsdonk JM, Warby SC, Hayden MR.
    Brain Res Bull; 2007 Apr 30; 72(2-3):124-31. PubMed ID: 17352936
    [Abstract] [Full Text] [Related]

  • 9. Huntington's disease gene: regional and cellular expression in brain of normal and affected individuals.
    Landwehrmeyer GB, McNeil SM, Dure LS, Ge P, Aizawa H, Huang Q, Ambrose CM, Duyao MP, Bird ED, Bonilla E.
    Ann Neurol; 1995 Feb 30; 37(2):218-30. PubMed ID: 7847863
    [Abstract] [Full Text] [Related]

  • 10. The selective vulnerability of nerve cells in Huntington's disease.
    Sieradzan KA, Mann DM.
    Neuropathol Appl Neurobiol; 2001 Feb 30; 27(1):1-21. PubMed ID: 11298997
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms of copper ion mediated Huntington's disease progression.
    Fox JH, Kama JA, Lieberman G, Chopra R, Dorsey K, Chopra V, Volitakis I, Cherny RA, Bush AI, Hersch S.
    PLoS One; 2007 Mar 28; 2(3):e334. PubMed ID: 17396163
    [Abstract] [Full Text] [Related]

  • 12. Huntington aggregates may not predict neuronal death in Huntington's disease.
    Kuemmerle S, Gutekunst CA, Klein AM, Li XJ, Li SH, Beal MF, Hersch SM, Ferrante RJ.
    Ann Neurol; 1999 Dec 28; 46(6):842-9. PubMed ID: 10589536
    [Abstract] [Full Text] [Related]

  • 13. Huntington's disease.
    Roze E, Bonnet C, Betuing S, Caboche J.
    Adv Exp Med Biol; 2010 Dec 28; 685():45-63. PubMed ID: 20687494
    [Abstract] [Full Text] [Related]

  • 14. HD CAG repeat implicates a dominant property of huntingtin in mitochondrial energy metabolism.
    Seong IS, Ivanova E, Lee JM, Choo YS, Fossale E, Anderson M, Gusella JF, Laramie JM, Myers RH, Lesort M, MacDonald ME.
    Hum Mol Genet; 2005 Oct 01; 14(19):2871-80. PubMed ID: 16115812
    [Abstract] [Full Text] [Related]

  • 15. Loss-of-Huntingtin in Medial and Lateral Ganglionic Lineages Differentially Disrupts Regional Interneuron and Projection Neuron Subtypes and Promotes Huntington's Disease-Associated Behavioral, Cellular, and Pathological Hallmarks.
    Mehler MF, Petronglo JR, Arteaga-Bracho EE, Gulinello ME, Winchester ML, Pichamoorthy N, Young SK, DeJesus CD, Ishtiaq H, Gokhan S, Molero AE.
    J Neurosci; 2019 Mar 06; 39(10):1892-1909. PubMed ID: 30626701
    [Abstract] [Full Text] [Related]

  • 16. Are there multiple pathways in the pathogenesis of Huntington's disease?
    Aronin N, Kim M, Laforet G, DiFiglia M.
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun 29; 354(1386):995-1003. PubMed ID: 10434298
    [Abstract] [Full Text] [Related]

  • 17. Huntingtin protein colocalizes with lesions of neurodegenerative diseases: An investigation in Huntington's, Alzheimer's, and Pick's diseases.
    Singhrao SK, Thomas P, Wood JD, MacMillan JC, Neal JW, Harper PS, Jones AL.
    Exp Neurol; 1998 Apr 29; 150(2):213-22. PubMed ID: 9527890
    [Abstract] [Full Text] [Related]

  • 18. [From gene to disease; HD gene and Huntington disease].
    Maat-Kievit JA, Losekoot M, Roos RA.
    Ned Tijdschr Geneeskd; 2001 Nov 03; 145(44):2120-3. PubMed ID: 11723754
    [Abstract] [Full Text] [Related]

  • 19. Dopamine enhances motor and neuropathological consequences of polyglutamine expanded huntingtin.
    Cyr M, Sotnikova TD, Gainetdinov RR, Caron MG.
    FASEB J; 2006 Dec 03; 20(14):2541-3. PubMed ID: 17065224
    [Abstract] [Full Text] [Related]

  • 20. Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin.
    Bao J, Sharp AH, Wagster MV, Becher M, Schilling G, Ross CA, Dawson VL, Dawson TM.
    Proc Natl Acad Sci U S A; 1996 May 14; 93(10):5037-42. PubMed ID: 8643525
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.